Welcome to our dedicated page for Churchill Cap X SEC filings (Ticker: CCCX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Churchill Capital Corp X (CCCX) files with the U.S. Securities and Exchange Commission as a blank check company listed on Nasdaq. This SEC filings page allows investors to review the company’s regulatory documents, which are central to understanding its structure as a special purpose acquisition company and its proposed business combination with ColdQuanta, Inc. (Infleqtion).
Key filings for Churchill Capital Corp X include current reports on Form 8-K, which disclose material events. One such Form 8-K describes the Agreement and Plan of Merger and Reorganization among Churchill Capital Corp X, two merger subsidiaries, and ColdQuanta, Inc., and notes the confidential submission of a draft registration statement on Form S-4. Subsequent communications reference the filing of a joint Form S-4 that includes a preliminary proxy statement/prospectus for Churchill Capital Corp X shareholders.
Through this page, users can access the company’s registration statements, proxy materials related to the proposed transaction, and other Exchange Act reports. These documents outline the terms of the business combination, the securities to be issued, and the risk factors associated with the transaction and the combined company. They also provide details on Churchill Capital Corp X’s units, Class A ordinary shares, and warrants listed on Nasdaq.
Stock Titan enhances these filings with AI-powered summaries that explain complex sections in plain language, helping readers interpret items such as merger terms, forward-looking statements, and risk disclosures. As new filings are made available through EDGAR, they are reflected here so that investors can review the latest information on CCCX, the proposed Infleqtion merger, and any subsequent corporate actions.
Use this page to examine Churchill Capital Corp X’s 8-K reports, registration statements on Form S-4, and related proxy and prospectus materials, and to understand how the company’s SPAC structure and planned business combination are documented in its official SEC submissions.
Infleqtion, Inc. Schedule 13G discloses that Tyler Brous and affiliated LCP Quantum entities beneficially own 30,563,654 shares of Common Stock, equal to 14.1% of the class. The filing shows shared voting and dispositive power of 30,563,614 shares and notes Mr. Brous holds options exercisable for 34,740 shares. The reporting persons state they are filing jointly and expressly disclaim membership in a group. The signatures are dated 02/26/2026.
Infleqtion, Inc. reports Schedule 13G disclosures showing shared beneficial ownership stakes by Global Frontier entities and W. Grant Dollens. Global Frontier Investments, LLC (GFI) has 25,622,170 shares (11.84%); Global Frontier Quantum Opportunity Fund (GFQOF) holds 20,839,094 shares (9.63%); W. Grant Dollens is reported with 25,705,546 shares (11.87%). These percentages are calculated based on 216,471,927 shares outstanding as of February 13, 2026 as referenced in the filing.
The filing states shared voting and dispositive power for the Global Frontier entities and indicates GFQOF holds its shares for the benefit of its investors.
Infleqtion, Inc. has a new large shareholder group, as Maverick-affiliated funds filed a Schedule 13D reporting beneficial ownership of 19,976,664 common shares, or 9.2% of the company. The percentage is based on 216,471,927 shares outstanding, including options for 34,740 shares.
The Maverick entities and principals Lee S. Ainslie III and David B. Singer state they hold the position for investment purposes, funded with working capital from various Maverick funds. They may buy more or sell shares over time, and may discuss Infleqtion’s strategy and ways to maximize stockholder value with management and other stakeholders, but currently report no specific plans for major corporate actions.
Churchill Capital Corp X/Cayman received an initial Form 3 from investment adviser Maverick Capital and related reporting persons, detailing their indirect holdings of the company’s common stock and options as of February 13, 2026. The filing lists several large blocks of common stock held through Maverick-managed funds and accounts, including holdings of 9,816,912 shares and 6,217,382 shares, along with additional smaller positions in other vehicles. It also reports stock option positions labeled as a right to buy, with 34,740 and 29,950 options outstanding, tied to director compensation for David B. Singer. One third of the shares underlying these options vest on February 17, 2027, with the remainder vesting monthly thereafter, and the economic benefit of this director compensation is directed to a Maverick-related fund. Each reporting owner disclaims beneficial ownership beyond its or his pecuniary interest.
Infleqtion, Inc. director David B. Singer reported receiving two grants of stock options totaling 64,690 options. One block of 34,740 fully vested options reflects legacy ColdQuanta, Inc. awards that were automatically converted into Infleqtion options in connection with the Churchill Capital Corp X–ColdQuanta mergers and subsequent name change to Infleqtion, Inc.
The second grant covers 29,950 options tied to his board service, with one-third vesting on February 17, 2027 and the remainder vesting monthly over three years, subject to continued service. The economic benefit of his director compensation flows to Maverick Ventures Investment Fund, L.P. through a management fee offset, and Singer disclaims beneficial ownership except to the extent of his pecuniary interest.
Churchill Capital Corp X/Cayman director reports option grant tied to merger. Dawn Clawson Meyerriecks acquired stock options for 347,403 shares of Infleqtion, Inc. on February 13, 2026, at an exercise price of $0.00 per share. These options are fully vested and were received under a merger agreement dated September 8, 2025, in which Churchill Capital Corp X combined with ColdQuanta, Inc. and changed its name to Infleqtion, Inc. Legacy ColdQuanta stock options were automatically converted into options of Infleqtion with the same terms and conditions.
Infleqtion, Inc. director Kristina M. Johnson reported equity awards linked to the merger of Churchill Capital Corp X with ColdQuanta. She was granted 373,458 stock options at an exercise price of $0.00 per share, which vest monthly from June 1, 2024 in 36 equal installments, contingent on continued service.
Johnson also reported an acquisition of 33,120 shares of common stock for $0.00 per share. These shares are held indirectly by Catalyzer Ventures, LP Fund I, over which she has voting and investment power and may therefore be deemed a beneficial owner.
Churchill Capital Corp X/Cayman director James Eric Bjornholt reported an option grant. He acquired a stock option covering 29,950 shares of the company’s stock. According to the vesting terms, one-third of the option vests on February 17, 2027, and the remaining shares vest in equal monthly installments over the following three years, conditioned on his continued service.
Catherine P. Lego, a director of Infleqtion, Inc. (formerly Churchill Capital Corp X), reported stock awards tied to the company’s merger with ColdQuanta, Inc. She acquired 477,680 shares of common stock directly and 82,801 shares indirectly through Lego Holdings, LP as merger consideration.
Footnotes state these shares were issued upon conversion of the Company’s Series C-1 preferred stock in the completed merger structure. Of the reported shares, 103,739 are subject to Infleqtion’s right of repurchase and vest monthly in equal installments until December 10, 2026, contingent on her continued service.
Infleqtion, Inc. (formerly Churchill Capital Corp X) reported that Chief Revenue Officer Paul Lipman received multiple grants of stock options on February 13, 2026. These derivative awards include a grant for 555,844 stock options and several additional option grants at an exercise price of $0.00 per share.
According to the disclosure, the options were received in connection with merger transactions completed under a September 8, 2025 agreement, where legacy ColdQuanta, Inc. options were converted into Infleqtion options with the same terms and conditions. Some options are fully vested, while others vest in equal monthly installments beginning on February 17, 2026, contingent on continued service.